Medical News

RSS

Tackling physical, mental health of prisoners would improve public health, researchers say

Providing the more than 10 million people incarcerated around the world "with better health care could prevent outbreaks of HIV and tuberculosis from spilling over into the general population experts say," the Associated Press/Washington Post reports.

20 Nov 2010

PIPC's white paper provides guidance in defining CER procedures

The Partnership to Improve Patient Care today released a white paper that defines a Procedural Framework for the Conduct of Comparative Effectiveness Research. The paper and its executive summary provide guidance for policy-makers, patient and providers for establishing CER procedures that foster openness, transparency and patient-centeredness.

20 Nov 2010

One-third of malaria-endemic countries are complying with WHO malaria drug efficacy monitoring standards, report says

Thirty-four percent of malaria-endemic countries are complying with WHO guidelines to monitor artemisinin resistance within their borders, the agency said in a report on Thursday, CBS News reports (11/18). Reuters reports that artemisinin "is the best drug available against malaria, especially when used in artemisinin combination therapy (ACT), which combines it with other drugs that finish off the [malaria] parasite" (Nebehay, 11/18).

20 Nov 2010

Pfizer's Phase 3 AXIS 1032 trial for metastatic renal cell carcinoma meets primary endpoint

Pfizer Inc. announced today that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC), has met its primary endpoint, demonstrating that axitinib significantly extended progression-free survival when compared to sorafenib, in the study population.

20 Nov 2010

UH physicists study workings of PGK enzyme that may cause Alzheimer's, cancer

University of Houston physicists are using complex computer simulations to illuminate the workings of a crucial protein that, when malfunctioning, may cause Alzheimer's and cancer.

20 Nov 2010

Platelet Rich Plasma Therapy reduces pain and improves function in knee osteoarthritis patients

The first American study that positions Platelet Rich Plasma Therapy (PRP) as a viable means in managing knee osteoarthritis, appeared today in the December issue of the American Journal of Physical Medicine & Rehabilitation (AJPMR). The study, authored by Dr. Steven Sampson of the Orthohealing Center in Los Angeles, details the account of 14 patients with primary and secondary knee osteoarthritis receiving three platelet-rich plasma injections in the affected knee at 4-week intervals with one year follow up.

20 Nov 2010

Siemens to unveil Biograph mMR system at RSNA Annual Meeting

At the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 28 - December 2 in Chicago, Siemens Healthcare (Booth #822, East Building/Lakeside Center, Hall D) will unveil the Biograph mMR, the world's first integrated whole-body molecular Magnetic Resonance (MR) system with simultaneous data acquisition technology, currently undergoing clinical use testing.

20 Nov 2010

VeriStrat analysis shows patients with advanced NSCLC benefit from dual targeted therapies

Results from the VeriStrat analysis of a phase II trial of first line erlotinib in combination with sorafenib in patients with advanced non-small cell lung cancer were presented today at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets in Cancer Therapeutics being held in Berlin, Germany by Egbert Smit, MD, PhD of the VU Medical Center, Amsterdam, The Netherlands.

20 Nov 2010

Discovery could provide new approaches to treat metabolic disorders

Scientists from the Florida campus of The Scripps Research Institute have identified a novel synthetic activator of a pair of proteins that belong to a protein family playing key roles in human metabolism and immune function. The discovery could provide new and potentially more effective therapeutic approaches to diseases ranging from diabetes to osteoporosis.

20 Nov 2010

IMRIS common shares commence trading on NASDAQ Global Market

IMRIS Inc. announced today that its common shares have commenced trading on the NASDAQ Global Market under the symbol "IMRS". IMRIS' common shares are dual listed on the Toronto Stock Exchange and the NASDAQ Global Market.

20 Nov 2010

Repeal, replace and revise are the new health overhaul buzzwords as congressional power changes hands

Senate Minority Leader Mitch McConnell and 32 other GOP senators officially filed a brief on Thursday in favor of a court case challenging healthcare reform. McConnell filed a 16-page brief in a federal case based in Florida arguing that a key part of the new healthcare law, the requirement that all individuals have health insurance, was unconstitutional.

20 Nov 2010

NEXTERONE Premixed Injection uses CyDex Captisol technology platform

CyDex Pharmaceuticals, Inc. today announced that Prism Pharmaceuticals' NEXTERONE (amiodarone HCL) Premixed Injection, which recently received supplemental new drug application (sNDA) approval from the U.S. Food and Drug Administration, makes use of the patent-protected CyDex Captisol technology platform.

20 Nov 2010

Study highlights poor outcomes for patients with ESRD admitted over weekend

Patients with end-stage renal disease who are admitted to the hospital during the weekend are at increased risk of death, according to a study presented at the American Society of Nephrology's 43rd Annual Meeting and Scientific Exposition.

20 Nov 2010

GE Healthcare Canada wins ITAC 2010 Company of the Year Award

GE Healthcare Canada, a global leader in information technology, has won the Information Technology Association of Canada's (ITAC) 2010 Company of the Year Award. This award recognizes a distinguished for-profit healthcare IT company that has demonstrated excellence in the Canadian health informatics industry over the past twelve months. GE Healthcare won the award as the solutions provider for several major image exchange projects funded by Canada Health Infoway and eHealth Ontario.

20 Nov 2010

NJISA experts to discuss science, impact and current state of Alzheimer's disease in America

The New Jersey Institute for Successful Aging (NJISA) at the UMDNJ-School of Osteopathic Medicine, one of the country's leading providers of geriatric care, research and education, is making experts available who can discuss the science, impact and current state of Alzheimer's disease in America.

20 Nov 2010

Xanodyne Pharmaceuticals decides to voluntarily remove propoxyphene from the U.S. market

Xanodyne Pharmaceuticals Inc. which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food and Drug Administration. The FDA has also informed the generic manufacturers of propoxyphene-containing products of Xanodyne's decision and requested that they voluntarily remove their products as well.

20 Nov 2010

NexACT technology improves oral delivery of five small molecule drugs

Apricus Biosciences, Inc., today announced data from animal studies showing that the NexACT technology significantly improved the oral delivery of five small molecule drugs tested, with the best improvements up to 20-fold, in terms of improvement in absorption.

20 Nov 2010

Anthem Blue Cross and Blue Shield in Nevada receives award for Our Health Connects Us campaign

Anthem Blue Cross and Blue Shield in Nevada, together with its agency, Deutsch LA, received a 2010 CLIO Healthcare Award for its "Our Health Connects Us" campaign. The bronze level award in the Integrated Campaign category was presented on November 12th at a ceremony in New York City.

20 Nov 2010

Boston Scientific signs definitive agreement to acquire Sadra Medical

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which Boston Scientific will acquire Sadra Medical, Inc., a development-stage company in Los Gatos, California. Sadra is developing the first fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis.

20 Nov 2010

Health industry players offer insights, expectations about overhaul's impact

Republicans made major gains in the midterm election, running vowing to "repeal and replace" the health law passed with solely Democratic votes earlier this year.

20 Nov 2010

Medical News

Tackling physical, mental health of prisoners would improve public health, researchers say

PIPC's white paper provides guidance in defining CER procedures

One-third of malaria-endemic countries are complying with WHO malaria drug efficacy monitoring standards, report says

Pfizer's Phase 3 AXIS 1032 trial for metastatic renal cell carcinoma meets primary endpoint

UH physicists study workings of PGK enzyme that may cause Alzheimer's, cancer

Platelet Rich Plasma Therapy reduces pain and improves function in knee osteoarthritis patients

Siemens to unveil Biograph mMR system at RSNA Annual Meeting

VeriStrat analysis shows patients with advanced NSCLC benefit from dual targeted therapies

Discovery could provide new approaches to treat metabolic disorders

IMRIS common shares commence trading on NASDAQ Global Market

Repeal, replace and revise are the new health overhaul buzzwords as congressional power changes hands

NEXTERONE Premixed Injection uses CyDex Captisol technology platform

Study highlights poor outcomes for patients with ESRD admitted over weekend

GE Healthcare Canada wins ITAC 2010 Company of the Year Award

NJISA experts to discuss science, impact and current state of Alzheimer's disease in America

Xanodyne Pharmaceuticals decides to voluntarily remove propoxyphene from the U.S. market

NexACT technology improves oral delivery of five small molecule drugs

Anthem Blue Cross and Blue Shield in Nevada receives award for Our Health Connects Us campaign

Boston Scientific signs definitive agreement to acquire Sadra Medical

Health industry players offer insights, expectations about overhaul's impact

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News